Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Conversely, the initial significant association between 25(OH)D concentrations and Italian geographic region of residence (p < 0.001) was no longer significant following seasonal correction (p = 0.238).

Source: 3.1. Associations Between Vitamin Concentrations and Clinical Parameters. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This multicenter cross-sectional cohort study was conducted in collaboration with general practitioners (GPs) across Italy.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Full studies

Serum Vitamin D, A, and E Concentrations and Their Associations with Chronic Diseases in Adult Patients Referred to Italian General Practitioners’ Offices

Cohort study · Nutrients · 2026

Original publication title

Serum Vitamin D, A, and E Concentrations and Their Associations with Chronic Diseases in Adult Patients Referred to Italian General Practitioners’ Offices

Paolo Baron; Diego Bigotto; Elena Brignolo; Gabriella Maria Camusso; Alberto Cannavino; Norberto Carli; Francesco Castronuovo; Carmine Colleluori; Provvidenza Fazio; Roberto Ferroni Nichelino; Giorgio Fiorello Chieri; Francesco Fontana; Lino Gambardelli; Patrizia Mascarello; Gabriella Musica; Claudio Nardo; Immacolata Piccirillo; Herbert Rainer; Alberto Rolfo; Stefano Vignando; Sara Cmet; Annarosa Cussigh; Edmondo Falleti; Pierluigi Toniutto

© 2026 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

In conclusion, this study demonstrates that vitamin D insufficiency is highly prevalent in Italian general practice populations, affecting most surveyed individuals with a median concentration below recommended thresholds. Although vitamin A concentrations were within normal ranges on average, they showed significant and independent associations with multiple chronic diseases and comorbidities, including cancer, diabetes mellitus, and arterial hypertension. The specific relationship between elevated vitamin A and multimorbidity suggests complex metabolic interactions that warrant further investigation through prospective cohort studies and mechanistic research.

Vitamin E showed limited associations with clinical outcomes in this population, consistent with recent trial evidence [14] questioning its clinical utility for chronic disease prevention. These findings highlight the importance of comprehensive vitamin status assessment in primary care settings and suggest that vitamin A metabolism may represent an underappreciated marker of metabolic health and disease burden. Future prospective studies with repeated measurements, detailed dietary and supplement data, assessment of genetic variants affecting vitamin metabolism, and mechanistic investigations are needed to clarify the causal relationships between vitamin status and chronic disease development, ultimately informing evidence-based screening and intervention strategies in general practice populations.

In the meantime, it remains of paramount importance to strictly adhere to dietary guidelines, avoiding a delayed implementation of existing intervention strategies, when the current results do not indicate any deficiencies in them.

An extract from the source publication. Read it in context.

At a glance

Study background

What background does the paper provide?

Vitamins are essential micronutrients that play critical roles in maintaining human health and preventing chronic diseases. Among fat-soluble vitamins, vitamins D, A, and E have been extensively studied for their diverse biological functions, including immunomodulation, antioxidant activity, and cellular differentiation [1,2,3]. Despite their well-established importance, vitamin deficiencies remain prevalent worldwide, contributing to increased morbidity and mortality from chronic non-communicable diseases [4,5].

Vitamin D, primarily recognized for its role in calcium homeostasis and bone metabolism, has emerged as a crucial regulator of multiple physiological processes beyond skeletal health [6,7]. Observational studies have consistently demonstrated an inverse association between vitamin D status and the risk of major chronic diseases, including type 2 diabetes, cardiovascular disease, and cancer [8,9,10]. Recent evidence from large-scale epidemiological studies indicates that vitamin D deficiency affects an estimated 50% or more of populations in both developed and developing countries, with a particularly high prevalence among older adults and specific ethnic groups [2,11].

The 2024 Endocrine Society Clinical Practice Guidelines have updated recommendations for vitamin D assessment and supplementation, emphasizing the need for targeted interventions in high-risk populations while recognizing ongoing debates regarding optimal serum levels and universal supplementation strategies [12,13].

Vitamin A, encompassing both preformed retinol and provitamin A carotenoids, is essential for vision, immune function, cellular differentiation, and epithelial integrity [14,15]. While severe vitamin A deficiency has been largely eradicated in developed countries through food fortification programs, subclinical deficiency and, conversely, excessive intake remain areas of clinical concern [16]. The relationship between vitamin A status and chronic disease exhibits complexity, with both deficiency and excess potentially associated with adverse health outcomes [17,18].

Recent systematic reviews and meta-analyses have revealed mixed findings regarding the association between vitamin A intake or serum levels and cancer risk, with some studies suggesting protective effects for certain malignancies, while others indicate potential harm, particularly in specific populations such as smokers receiving high-dose beta-carotene supplementation [19,20,21]. Furthermore, emerging evidence suggests that elevated serum vitamin A levels may be associated with metabolic dysfunction and chronic inflammatory states, although the directionality of this relationship: whether causative or consequential: remains unclear [22,23,24].

Vitamin E, comprising eight naturally occurring isomers (four tocopherols and four tocotrienols), functions primarily as a lipophilic antioxidant protecting cellular membranes from oxidative damage [25]. Alpha-tocopherol, the most biologically active form, has been studied extensively for its potential role in preventing cardiovascular disease, cancer, and neurodegenerative disorders [26,27]. However, despite compelling biological mechanisms and promising observational data, large randomized controlled trials have generally failed to demonstrate consistent clinical benefits of vitamin E supplementation for chronic disease prevention [28,29].

Recent meta-analyses examining vitamin E anti-inflammatory properties have shown modest reductions in inflammatory biomarkers such as C-reactive protein and interleukin-6, particularly at higher supplementation doses, yet translation of these effects into clinically meaningful outcomes remains elusive [30]. The European Food Safety Authority’s 2024 scientific opinion on tolerable upper intake levels for vitamin E has reinforced concerns about potential adverse effects, particularly increased bleeding risk, emphasizing the importance of understanding both deficiency and excess states in clinical populations [31].

The interplay between vitamin status and chronic disease development is further complicated by multiple factors, including genetic polymorphisms affecting vitamin metabolism, concurrent medications, dietary patterns, and comorbid conditions that alter absorption and utilization [32,33]. Moreover, the metabolic relationships among different vitamins and their roles in shared pathophysiological pathways suggest that assessment of multiple vitamin status simultaneously may provide more comprehensive insights into disease risk than evaluation of individual vitamins in isolation [34].

General practice settings represent an ideal environment for evaluating vitamin status in community-dwelling adults, as general practitioners serve as first-line healthcare providers with access to diverse patient populations across a wide age spectrum. However, limited data exist regarding the distribution of vitamin D, A, and E concentrations in primary care populations and their associations with common chronic comorbidities encountered in clinical practice.

Therefore, this cross-sectional cohort study aimed to evaluate serum concentrations of vitamins D, A, and E in a cohort of adult patients attending general practice offices throughout Italy, and to examine the associations between these vitamin levels and prevalent chronic diseases, including cardiovascular disease, diabetes mellitus, osteoporosis, and malignancy. By characterizing vitamin status and its clinical correlates in this population, we sought to identify patterns that might inform screening strategies and preventive interventions in primary care settings.

Source: 1. Introduction Source: 1. Introduction Source: 1. Introduction Source: 1. Introduction Source: 1. Introduction Source: 1. Introduction Source: 1. Introduction

Study methods

What methods does the paper describe?

2.1. Study Protocol

This multicenter cross-sectional cohort study was conducted in collaboration with general practitioners (GPs) across Italy. The study protocol was proposed to multiple GPs working in Northern, Central, and Southern Italy through the Italian GP Federation. Following protocol review, 21 Italian GPs (18 from Northern Italy, 2 from Central Italy, and 1 from Southern Italy) agreed to participate in this study. The protocol was approved by the Internal Review Board of the University of Udine and conducted in accordance with the Declaration of Helsinki.

Each enrolled patient provided written informed consent, which was administered by their respective GP. Serum vitamins level measurements and determination of cut-off values of normality were performed in all the laboratories referring to GPs areas following these methods: for 25-OH-vitamin D, by an immunoassay method (<10 ng/mL: deficiency, 10 to 30: insufficiency, and >30: sufficiency) [2]; for vitamin A, by a reversed-phase HPLC method focused on a retinol-only form (normal values: 300 to 800 microg/L); and vitamin E, by alpha-tocopherol (normal values: 5.5 to 18 mg/L) [35].

2.2. Study Population

The study population comprised adult subjects aged 18 to 70 years attending the offices of the 18 participating Italian GPs between 1 January 2021 and 31 December 2024. Each GP identified among his patients who did not report taking any vitamin supplements, those in whom at least one measurement of serum vitamins D, A, and E was available during this period. Vitamin measurements may have been performed for specific clinical indications or proposed by the GP as part of a routine health assessment.

For each enrolled patient, additional laboratory parameters were collected, including serum levels of parathyroid hormone (iPTH), calcium, phosphorus, uric acid, and creatinine.

After anonymization using numerical codes assigned by each participating GP, the following data were systematically collected from practice management systems: date of data collection, GP identification details, patient demographic characteristics (region of residence, gender, age, and ethnicity, categorized as Caucasian or other), anthropometric measurements (body mass index, calculated as weight in kilograms divided by height in meters squared), occupational status (employed, casual work, unemployed, student, or retired), educational attainment (primary school, middle school, high school, or university (college) degree), smoking history (never, past, or current smoker), and presence of chronic diseases, including malignancy (active or past), cardiovascular disease, stroke, diabetes mellitus, arterial hypertension, respiratory disease, and osteoporosis.

All clinical diagnoses and demographic information reflected the status recorded in the patient file at the time of enrollment. Patient age was calculated from the enrollment date.

2.3. Data Management

Each participating GP entered the collected data into a standardized Microsoft Excel spreadsheet, with each row representing an individual patient code and each column representing a specific variable. Upon completion of data entry, patient records remained in the possession of the individual GP responsible for patient care. For statistical analysis purposes, only anonymized datasets were transmitted to the study statistician.

2.4. Statistical Analysis

Statistical analysis was performed using the Stata 15.1 statistical software (StataCorp, 2017; Stata Statistical Software: Release 15; College Station, TX, USA: StataCorp LLC). Categorical variables were expressed as absolute numbers and percentages, while continuous variables were presented as median values with interquartile ranges. Associations between categorical variables were evaluated using the chi-square test, with the test for linear trend applied when appropriate. The Spearman nonparametric test was used to correlate variables, and the Mann: Whitney test was used to compare the values of vitamins in patients with or without disease.

Stepwise logistic regression analysis was utilized to identify independent predictors of vitamins D, A, and E deficiency. A two-tailed p-value of less than 0.05 was considered statistically significant.

Source: 2. Materials and Methods Source: 2. Materials and Methods Source: 2. Materials and Methods Source: 2. Materials and Methods

Associations Between Vitamin Concentrations and Clinical Parameters

Results: Associations Between Vitamin Concentrations and Clinical Parameters

Table 3 presents the relationships between serum concentrations of vitamins D, A, and E and the principal demographic, clinical, and laboratory parameters.

25-Hydroxyvitamin D: A statistically significant inverse correlation was observed between age and serum 25(OH)D concentrations (p < 0.001), which persisted after adjustment for the season in which vitamin D measurement was performed (winter versus summer) (p < 0.001). Conversely, the initial significant association between 25(OH)D concentrations and Italian geographic region of residence (p < 0.001) was no longer significant following seasonal correction (p = 0.238). A significant inverse correlation between 25(OH)D levels and serum PTH was documented (p < 0.001), remaining significant after seasonal adjustment (p < 0.001).

Among social and biochemical parameters, a significant positive correlation was identified between 25(OH)D concentrations and platelet count (p = 0.066 before seasonal correction; p = 0.004 after seasonal correction).

Vitamin A: Significant positive correlations were found between vitamin A serum concentrations and male gender (p < 0.001), body mass index (p < 0.001), serum creatinine (p < 0.001), serum uric acid (p < 0.001), serum calcium (p < 0.001), white blood cell count (p < 0.001), hemoglobin concentration (p < 0.001), and platelet count (p < 0.001).

Vitamin E. Significant positive correlations were observed between vitamin E serum concentrations and age (p < 0.001), Italian geographic region of residence (p < 0.001), serum PTH (p = 0.002): which remained significant after seasonal correction (p = 0.009): as well as hemoglobin concentration (p < 0.001) and platelet count (p < 0.001).

Table 3

Vitamin D, vitamin A, and vitamin E serum concentrations in relation to demographic, clinical, and biochemical parameters in the studied population. Spearman’s rank correlation coefficient rho (r) was calculated and is presented.

25-OH-Vitamin D25-OH-Vitamin D
(Corrected for Season)
Vitamin AVitamin E
Corr. Coeff.
ρ
p Corr. Coeff.
ρ
p Corr. Coeff.
ρ
p Corr. Coeff.
ρ
p
Age (years)−0.2010<0.001−0.1533<0.0010.07880.07850.2785<0.001
Gender (f = 0/m = 1)−0.00300.94650.00650.88430.2023<0.001−0.00150.9726
Living region
North Italy (0)
Central Italy (1)
South Italy (2)
0.1950<0.0010.05280.2383−0.08880.0472−0.4578<0.001
Education (0 = primary, 1 = middle, 2 = high, or 3 = university)0.07760.08290.07060.1148−0.01850.6806−0.12020.0071
Job (0 = no, 1 = occasional, 2 = stable, 3 = retired, or 4= student)−0.04300.33730.00070.9878−0.00730.87130.07330.1017
BMI (Kg/m2)−0.03980.3743−0.03300.46210.2157<0.0010.03510.4336
Smoking (no = 0/y = 1)0.02150.63090.01880.67440.12430.0054−0.02770.5360
Creatinine (mg/dL)−0.05060.2589−0.01380.75840.3098<0.0010.06620.1395
Uric acid (mg/dL)−0.03340.4556−0.01770.69370.3186<0.0010.05600.2115
Ca (mMol/L)0.07810.08120.07550.09160.2133<0.0010.06010.1796
P (mMol/L)0.05950.18410.01640.7143−0.08460.05870.02810.5301
iPTH (pg(mL)−0.3407<0.001−0.3007<0.001−0.10300.02120.13660.0022
iPTH (pg(mL) season-corrected)−0.3303<0.001−0.3072<0.001−0.10600.01780.11530.0099
WBCs (n * 1000/mL)−0.00460.9174−0.01220.78510.2702<0.001−0.03790.3977
Hemoglobin (g/dL)0.02090.64120.06140.17050.2386<0.0010.1480<0.001
Platelets (n * 1000/mL)0.0840.06580.12830.00410.1489<0.0010.1793<0.001

BMI: body mass index; WBCs: white blood cells; Ca: serum calcium, P: serum phosphorus; iPTH: serum parathormone.

Source: 3.1. Associations Between Vitamin Concentrations and Clinical Parameters Source: 3.1. Associations Between Vitamin Concentrations and Clinical Parameters Source: 3.1. Associations Between Vitamin Concentrations and Clinical Parameters Source: 3.1. Associations Between Vitamin Concentrations and Clinical Parameters Source: 3.1. Associations Between Vitamin Concentrations and Clinical Parameters

Vitamin Concentrations and Clinical Diseases

Results: Vitamin Concentrations and Clinical Diseases

Table 4 presents the correlations between serum concentrations of vitamins D, A, and E and the clinical characteristics of the study population.

Vitamin D: Median serum 25(OH)D concentrations were significantly lower in patients with osteoporosis compared with those without (18.1 vs. 21.1 ng/mL; p = 0.015), in patients with arterial hypertension versus those without (19.2 vs. 21.1 ng/mL; p = 0.047), and in patients with CAD versus those without (13.7 vs. 20.6 ng/mL; p = 0.002).

Vitamin A: Significantly elevated median serum vitamin A concentrations were observed in patients with arterial hypertension compared with those without (670 vs. 647 μg/L; p = 0.005), in patients with diabetes mellitus versus those without (693 vs. 650 μg/L; p = 0.036), and in patients with cancer versus those without (727 vs. 650 μg/L; p = 0.010). Patients with vitamin A over 800 μg/L have a higher cancer presence (15/102 [14.7%] vs. 23/398 [5.8%]; p = 0.002).

Vitamin E: The only statistically significant correlation was higher vitamin E serum concentrations in patients presenting osteoporosis compared with those who did not (18.1 vs. 11.0 mg/L; p = 0.008).

Table 5 displays the univariate and multivariate analyses examining independent predictors of having no or one (N = 412) or more (N = 88) baseline clinical diseases in the study population. In univariate analysis, age (p < 0.001), male gender (p < 0.001), living region (p = 0.001), education level (p < 0.001), job (p = 0.003), BMI (p < 0.001), creatinine (p < 0.001), uric acid (p < 0.001), phosphorus (p = 0.0127), and vitamin A (p = 0.002) were significantly associated with multiple chronic diseases.

In multivariate analysis, independent predictors of having multiple clinical diseases included older age (p < 0.001), male gender (p = 0.003), increased BMI (p = 0.021), and elevated serum vitamin A concentrations (p < 0.001). A linear trend was detected between the number of patients with a vitamin A serum concentration above the upper limit and the presence of one or more chronic diseases (no disease= 16.3%, one = 19.7%, and two or more = 27.3%; linear trend p < 0.001 Supplementary Figure S1).

Furthermore, as shown in Table 6, elevated vitamin A serum concentrations, in addition to older age, emerged as independent predictors of prevalent cancer at baseline in the multivariate analysis. In the univariate analysis, age (p < 0.001), male gender (p = 0.022), living region (p = 0.018), creatinine (p = 0.048), uric acid (p = 0.023), and vitamin A (p = 0.010) were associated with cancer presence. In the multivariate model, only age (p < 0.001) and vitamin A (p = 0.014) remained as independent predictors.

Additionally, a progressive increase in vitamin A serum concentrations was significantly associated with an increasing number of chronic diseases present at baseline (Figure 1), demonstrating a potential dose: response relationship between vitamin A levels and multimorbidity.

Table 4

25-OH-vitamin D, vitamin A and vitamin E serum concentrations in relation to the presence of diseases evaluated in the studied population. Medians (interquartile ranges) and rank-sum test (Mann: Whitney) comparisons are presented.

25-OH-Vitamin D
(ng/mL)
Vitamin A
(mg/L)
Vitamin E
(mg/L)
PresentAbsent p PresentAbsent p PresentAbsent p
Osteoporosis
(N = 107)
18.1
(11.6 to 25.6)
21.1
(14.9 to 26.2)
0.0146670
(570 to 800)
645
(544 to 766)
0.060118.1
(11.6 to 25.6)
11.0
(7.8 to 13.8)
0.0082
Arterial hypertension
(N = 173)
19.2
(12.8 to 25.1)
21.1
(15.0 to 26.4)
0.0473670
(570 to 808)
647
(532 to 758)
0.004711.8
(9.0 to 14.3)
10.8
(7.8 to 14.0)
0.0846
Diabetes
(N = 55)
22.3
(13.5 to 28.3)
20.2
(14.1 to 26.0)
0.2715693
(551 to 905)
650
(548 to 763)
0.036311.2
(7.6 to 13.7)
11.3
(8.4 to 14.2)
0.4409
Respiratory diseases
(N = 28)
18.8
(12.4 to 24.5)
20.5
(14.3 to 26.4)
0.1115621
(501 to 744)
656
(554 to 772)
0.318810.8
(9.2 to 12.3)
11.4
(8.1 to 14.3)
0.5902
CAD
(N = 27)
13.7
(8.7 to 23.7)
20.6
(14.6 to 26.3)
0.0017625
(538 to 733)
655
(551 to 772)
0.363511.0
(8.4 to 13.6)
11.3
(8.2 to 14.1)
0.6787
History of stroke
(N = 11)
20.0
(12.8 to 31.8)
20.5
(14.1 to 26.1)
0.9470745
(518 to 870)
625
(551 to 770)
0.28009.0
(7.6 to 12.3)
11.4
(8.2 to 14.2)
0.1102
Presence of cancer
(N = 38)
16.7
(12.4 to 24.3
20.5
(14.4 to 26.2)
0.1387727
(574 to 880)
650
(545 to 763)
0.010112.1
(9.6 to 14.1)
11.2
(8.1 to 14.1)
0.1743

CAD: coronary artery disease.

Table 5

Association between demographic, clinical, and biochemical parameters, and presenting at baseline one or less (N = 412) versus more than one (two to five) chronic disease (N = 88) in the studied population. Spearman’s rank correlation rho was calculated and presented in the univariate analysis. Stepwise logistic regression with a forward approach was used to discriminate variables independently associated with the presence of two or more diseases.

Presence of >1 Diseases at Baseline
Univariate AnalysisMultivariate Logistic
Regression Analysis
ρ p OR95% CI p
Age (years)0.32130.00001.0681.047 to 1.089<0.001
Gender (f = 0/m = 1)0.24030.00002.2591.330 to 3.8370.003
Living region
North Italy (0)
Central Italy (1)
South Italy (2)
−0.14460.0012Not reportedNot reportedNot reported
Education (0 = primary, 1 = middle, 2 = high, or 3 = university)−0.23780.0000Not reportedNot reportedNot reported
Job (0 = no, 1 = occasional, 2 = stable, 3 = retired, or 4= student)0.13230.0030Not reportedNot reportedNot reported
BMI (Kg/m2)0.21630.00001.0691.010 to 1.1310.021
Smoking (no = 0/y = 1)−0.02970.5072
Creatinine (mg/dL)0.19670.0000Not reportedNot reportedNot reported
Uric acid (mg/dL)0.24010.0000Not reportedNot reportedNot reported
Ca (mMol/L)0.02320.6052
P (mMol/L)−0.11130.0127
iPTH (pg/mL)0.06540.1441
WBCs (n * 1000/mL)0.01260.7785
Hemoglobin (g/dL)0.00750.8666
Platelets (n * 1000/mL)−0.06330.1578
25-OH-vitamin D (ng/mL)−0.07950.0758Not reportedNot reportedNot reported
Vitamin A (mg/L)0.14030.00171.0031.001 to 1.131<0.001
Vitamin E (mg/L)0.02400.5919

BMI: body mass index; WBCs: white blood cells; Ca: serum calcium, P: serum phosphorus; iPTH: serum parathormone.

Table 6

Association between demographic, clinical, and biochemical parameters (N = 500), with the presence of cancer at baseline in the studied population. Spearman’s rank correlation rho was calculated and presented in univariate analysis. Stepwise regression with a forward approach was used to discriminate variables independently associated with the presence of cancer.

Presence of Cancer (N = 38)
Univariate AnalysisMultivariate Logistic
Regression Analysis
ρ p OR95% CI p
Age (years)0.16910.00011.0441.019 to 1.069<0.001
Gender (f = 0/m = 1)0.10230.0222Not reportedNot reportedNot reported
Living region
North Italy (0)
Central Italy (1)
South Italy (2)
−0.10570.0181Not reportedNot reportedNot reported
Education (0 = primary, 1 = middle, 2 = high, or 3 = university)−0.04590.3054
Job (0 = no, 1 = occasional, 2 = stable, 3 = retired, or 4= student)0.05750.1991
BMI (Kg/m2)0.06490.1472
Smoking (no = 0/y = 1)−0.09070.0426Not reportedNot reportedNot reported
Creatinine (mg/dL)0.08840.0482Not reportedNot reportedNot reported
Uric acid (mg/dL)0.10170.0230Not reportedNot reportedNot reported
Ca (mMol/L)−0.02700.5462
P (mMol/L)−0.03340.4556
iPTH (pg/mL)−0.00550.9030
WBCs (n * 1000/mL)−0.02210.6217
Hemoglobin (g/dL)−0.01850.6796
Platelets (n * 1000/mL)−0.00550.9021
25-OH-vitamin D (ng/mL)−0.06630.1389
Vitamin A (mg/L)0.11510.01001.0021.000 to 1.0040.014
Vitamin E (mg/L)0.06080.1746

BMI: body mass index; WBCs: white blood cells; Ca: serum calcium, P: serum phosphorus; iPTH: serum parathormone.

Source: 3.2. Vitamin Concentrations and Clinical Diseases Source: 3.2. Vitamin Concentrations and Clinical Diseases Source: 3.2. Vitamin Concentrations and Clinical Diseases Source: 3.2. Vitamin Concentrations and Clinical Diseases Source: 3.2. Vitamin Concentrations and Clinical Diseases Source: 3.2. Vitamin Concentrations and Clinical Diseases Source: 3.2. Vitamin Concentrations and Clinical Diseases Source: 3.2. Vitamin Concentrations and Clinical Diseases Source: 3.2. Vitamin Concentrations and Clinical Diseases

Discussion

This cross-sectional cohort study examined serum concentrations of vitamins D, A, and E in a cohort of 500 adult subjects attending general practice offices throughout Italy, along with their associations with demographic characteristics, clinical comorbidities, and biochemical parameters. Our findings reveal distinct patterns for each vitamin, with important clinical and public health implications.

Regarding 25(OH)D, our results demonstrated that median serum concentrations (20.4 ng/mL) fell below the optimal range, consistent with the widespread vitamin D insufficiency reported in European and global populations [2,11]. The inverse correlation between vitamin D concentrations and age observed in our study aligns with previous literature demonstrating age-related decline in vitamin D status attributable to reduced cutaneous synthesis, decreased renal hydroxylation capacity, and diminished outdoor activity among older adults [6,7]. Importantly, this association persisted after seasonal correction, suggesting that age-related factors beyond sun exposure contribute to vitamin D deficiency.

The inverse relationship between 25(OH)D and parathyroid hormone concentrations confirms the well-established negative feedback mechanism in calcium: phosphate homeostasis [13,32].

Our findings of significantly lower vitamin D concentrations in patients with osteoporosis, arterial hypertension, and coronary artery disease are consistent with extensive epidemiological evidence linking vitamin D deficiency to multiple chronic conditions [8,9,10]. This evidence could be reinforced considering that a patient with chronic disease spends more time indoors than a healthy person, thus reducing the self-synthesis of vitamin D during sun exposure [36]. The association with osteoporosis is well documented, as vitamin D plays a crucial role in calcium absorption and bone metabolism [33,34].

Recent meta-analyses have confirmed that combined calcium and vitamin D supplementation modestly improves bone mineral density and may reduce fracture risk in postmenopausal women with osteoporosis, although the magnitude of benefit remains subject to debate [37,38]. The relationship with cardiovascular diseases, including hypertension and coronary artery disease, supports the hypothesis that vitamin D exerts pleiotropic effects beyond skeletal health, potentially through modulation of the renin: angiotensin: aldosterone system, endothelial function, and inflammatory pathways [9,10].

However, the 2024 Endocrine Society guidelines acknowledge that despite compelling observational associations, most randomized controlled trials have failed to demonstrate clear clinical benefits of vitamin D supplementation for cardiovascular disease prevention in the general population [12]. These findings underscore the importance of monitoring vitamin D status in populations at risk for these conditions while recognizing the complexity of translating observational associations into effective interventions.

The vitamin A findings present a more complex and clinically intriguing picture. While median serum concentrations were within the normal range (654 μg/L), we observed significantly elevated concentrations in patients with arterial hypertension, diabetes mellitus, and cancer. The positive correlations between vitamin A concentrations and male gender, BMI, creatinine, uric acid, and hematological parameters suggest that vitamin A metabolism may be influenced by metabolic and inflammatory status [22,23,24]. Most notably, elevated vitamin A emerged as an independent predictor of both multiple comorbidities and cancer presence at baseline, even after adjustment for age, gender, and BMI.

This finding requires careful interpretation, as the relationship between vitamin A and chronic diseases exhibits a U-shaped curve, with both deficiency and excess being potentially harmful [17,18]. The association between elevated vitamin A concentrations and cancer deserves particular attention and warrants mechanistic investigation. While vitamin A and its metabolites have traditionally been considered protective against carcinogenesis through their roles in cellular differentiation and immune function [14,15], recent evidence suggests that excessive vitamin A intake or elevated serum retinol concentrations may paradoxically increase cancer risk in certain populations [19,20,21].

Our observation that vitamin A concentrations progressively increased with the number of chronic diseases suggests that elevated vitamin A may serve as a biomarker of underlying metabolic dysfunction or chronic inflammatory states rather than a causative factor. Alternatively, reverse causation cannot be excluded, as chronic diseases may alter vitamin A metabolism, distribution, and clearance. The documented association between vitamin A and metabolic syndrome components, including insulin resistance and adiposity, provides a potential mechanistic link [39,40,41].

The positive correlations between vitamin A and markers such as creatinine, uric acid, and metabolic parameters may reflect hepatic and renal function alterations, as both organs play critical roles in vitamin A metabolism [22]. The liver stores approximately 80 to 90% of total body vitamin A as retinyl esters, and impaired hepatic or renal function can lead to altered vitamin A homeostasis [23]. Furthermore, insulin resistance and metabolic syndrome, conditions commonly associated with the comorbidities observed in our population, have been linked to altered retinoid metabolism and elevated circulating retinol-binding protein 4 (RBP4), which has emerged as an adipokine implicated in insulin resistance [39,40,41].

A further potential explanation of our findings is to consider that vitamin A per se cannot be the primary factor in determining the increased risk of chronic disease and cancer, but that products present in drinks or foods containing vitamin A may have a relevant role. There are two types of dietary sources of vitamin A: either plant foods containing β-carotene or animal foods containing retinyl esters. It has been shown that the conversion of β-carotene to retinol is under negative-feedback control, since a high vitamin A status inhibits the formation of the rate-limiting enzyme of this conversion [42,43].

This limits the level of retinol in the plasma, even if only part of the dietary vitamin A comes from plant sources. Thus, elevated vitamin A status is only possible if the animal foods in the diet provide an excess of the required retinol. However, the association between high vitamin A serum levels and diseases could be caused either by the vitamin A itself, by anything harmful that occurs primarily in animal-based foods, such as saturated fats or nitrosamines, or by a deficiency of something that does not primarily occur in animal-based food, such as fiber or phytochemicals [44].

The vitamin E results demonstrated a positive correlation with age and PTH concentrations, but, notably, no significant associations were found with clinical comorbidities besides osteoporosis. Vitamin E serum concentrations are regulated by a negative-feedback mechanism, ensuring that the plasma status matches the requirements [45]. Older people, particularly those with osteoporosis, may require more vitamin E to maintain the oxidative balance in their cells than people who do not have these risk factors. In this case, the high vitamin E serum levels would be a marker of oxidative dysfunction, rather than a cause of it [46].

The modest positive correlation between vitamin E and hematological parameters (hemoglobin and platelet counts) may also reflect the antioxidant role of vitamin E in protecting blood cells from oxidative damage [25], although this association lacks clinical significance in the absence of correlations with clinical endpoints. The lack of meaningful associations between vitamin E and chronic diseases contrasts with some earlier observational studies suggesting protective effects of vitamin E against cardiovascular disease and certain cancers [26,27].

However, our findings align with more recent large-scale randomized controlled trials that have failed to demonstrate clear clinical benefits of vitamin E supplementation in chronic disease prevention [28,29]. The ATBC trial and subsequent studies revealed either no benefit or potential harm from high-dose vitamin E supplementation [28].

The multivariate analysis identifying older age, male gender, elevated BMI, and elevated vitamin A concentrations as independent predictors of multiple comorbidities highlights the interconnected nature of metabolic health and vitamin status. The specific association between vitamin A and multimorbidity, independent of other traditional risk factors, suggests that vitamin A metabolism may be more intimately linked to systemic metabolic dysfunction than previously recognized. This finding warrants prospective studies to determine whether elevated vitamin A represents a consequence of chronic disease, a contributor to disease progression, or both.

Given the observational nature of our study, we cannot establish causality, and the observed association may reflect confounding by unmeasured factors or reverse causation.

Several limitations of this study merit consideration. First, the cross-sectional design precludes causal inferences regarding the relationships between vitamin concentrations and chronic diseases. Prospective longitudinal studies are needed to establish temporal relationships and determine whether vitamin status predicts disease incidence or represents a consequence of existing disease. Second, the study population was predominantly drawn from Northern Italy, potentially limiting generalizability to other geographic regions or ethnic groups with different dietary patterns, sun exposure, and genetic backgrounds. Third, single-point measurements of vitamin concentrations may not accurately reflect long-term vitamin status, and seasonal variations in vitamin D, despite statistical adjustments, remain a potential source of bias.

Finally, residual confounding from unmeasured variables, such as physical activity levels and genetic factors affecting vitamin metabolism, cannot be entirely excluded despite multivariate adjustment.

Despite these limitations, our study has several notable strengths. The relatively large sample size (n = 500) and inclusion of multiple sites across different Italian regions enhance the representativeness of our findings for primary care populations. The simultaneous assessment of three distinct vitamins provides a more comprehensive picture of vitamin status than studies focusing on individual vitamins. Additionally, the inclusion of diverse clinical and laboratory parameters, including hematological indices, renal function markers, and metabolic parameters, allowed for extensive exploration of potential associations and confounding factors.

Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion

Results

Subjects: Five hundred subjects were enrolled in this study. The principal demographic, social, and clinical characteristics of the study population are presented in Table 1. The median age was 60.7 years, and 40.4% of participants were male. Most patients resided in Northern Italy (72.4%), 17.6% were from Central Italy, and 10.0% were from Southern Italy. Approximately 40% were actively employed, while 32.3% were retired. More than half of the enrolled patients had attained higher educational levels, having completed middle school (37.2%) or high school education (30.2%).

Nearly one-third of patients had a diagnosis of arterial hypertension, 11.0% had diabetes mellitus, 17.2% had osteoporosis, 7.6% had cancer, 5.4% had coronary artery disease (CAD), and approximately 17.2% were current smokers.

The principal laboratory parameters evaluated at enrollment, including serum concentrations of 25-hydroxyvitamin D [25(OH)D], vitamin A, and vitamin E, are described in Table 2. Regarding vitamin status, only the median 25(OH)D concentration (20.4 ng/mL) fell below the optimal range, whereas median serum concentrations of both vitamin A (654 μg/L) and vitamin E (11.3 mg/L) were within normal reference ranges.

3.1. Associations Between Vitamin Concentrations and Clinical Parameters

Table 3 presents the relationships between serum concentrations of vitamins D, A, and E and the principal demographic, clinical, and laboratory parameters.

25-Hydroxyvitamin D: A statistically significant inverse correlation was observed between age and serum 25(OH)D concentrations (p < 0.001), which persisted after adjustment for the season in which vitamin D measurement was performed (winter versus summer) (p < 0.001). Conversely, the initial significant association between 25(OH)D concentrations and Italian geographic region of residence (p < 0.001) was no longer significant following seasonal correction (p = 0.238). A significant inverse correlation between 25(OH)D levels and serum PTH was documented (p < 0.001), remaining significant after seasonal adjustment (p < 0.001).

Among social and biochemical parameters, a significant positive correlation was identified between 25(OH)D concentrations and platelet count (p = 0.066 before seasonal correction; p = 0.004 after seasonal correction).

Vitamin A: Significant positive correlations were found between vitamin A serum concentrations and male gender (p < 0.001), body mass index (p < 0.001), serum creatinine (p < 0.001), serum uric acid (p < 0.001), serum calcium (p < 0.001), white blood cell count (p < 0.001), hemoglobin concentration (p < 0.001), and platelet count (p < 0.001).

Vitamin E. Significant positive correlations were observed between vitamin E serum concentrations and age (p < 0.001), Italian geographic region of residence (p < 0.001), serum PTH (p = 0.002): which remained significant after seasonal correction (p = 0.009): as well as hemoglobin concentration (p < 0.001) and platelet count (p < 0.001).

3.2. Vitamin Concentrations and Clinical Diseases

Table 4 presents the correlations between serum concentrations of vitamins D, A, and E and the clinical characteristics of the study population.

Vitamin D: Median serum 25(OH)D concentrations were significantly lower in patients with osteoporosis compared with those without (18.1 vs. 21.1 ng/mL; p = 0.015), in patients with arterial hypertension versus those without (19.2 vs. 21.1 ng/mL; p = 0.047), and in patients with CAD versus those without (13.7 vs. 20.6 ng/mL; p = 0.002).

Vitamin A: Significantly elevated median serum vitamin A concentrations were observed in patients with arterial hypertension compared with those without (670 vs. 647 μg/L; p = 0.005), in patients with diabetes mellitus versus those without (693 vs. 650 μg/L; p = 0.036), and in patients with cancer versus those without (727 vs. 650 μg/L; p = 0.010). Patients with vitamin A over 800 μg/L have a higher cancer presence (15/102 [14.7%] vs. 23/398 [5.8%]; p = 0.002).

Vitamin E: The only statistically significant correlation was higher vitamin E serum concentrations in patients presenting osteoporosis compared with those who did not (18.1 vs. 11.0 mg/L; p = 0.008).

Table 5 displays the univariate and multivariate analyses examining independent predictors of having no or one (N = 412) or more (N = 88) baseline clinical diseases in the study population. In univariate analysis, age (p < 0.001), male gender (p < 0.001), living region (p = 0.001), education level (p < 0.001), job (p = 0.003), BMI (p < 0.001), creatinine (p < 0.001), uric acid (p < 0.001), phosphorus (p = 0.0127), and vitamin A (p = 0.002) were significantly associated with multiple chronic diseases.

In multivariate analysis, independent predictors of having multiple clinical diseases included older age (p < 0.001), male gender (p = 0.003), increased BMI (p = 0.021), and elevated serum vitamin A concentrations (p < 0.001). A linear trend was detected between the number of patients with a vitamin A serum concentration above the upper limit and the presence of one or more chronic diseases (no disease= 16.3%, one = 19.7%, and two or more = 27.3%; linear trend p < 0.001 Supplementary Figure S1).

Furthermore, as shown in Table 6, elevated vitamin A serum concentrations, in addition to older age, emerged as independent predictors of prevalent cancer at baseline in the multivariate analysis. In the univariate analysis, age (p < 0.001), male gender (p = 0.022), living region (p = 0.018), creatinine (p = 0.048), uric acid (p = 0.023), and vitamin A (p = 0.010) were associated with cancer presence. In the multivariate model, only age (p < 0.001) and vitamin A (p = 0.014) remained as independent predictors.

Additionally, a progressive increase in vitamin A serum concentrations was significantly associated with an increasing number of chronic diseases present at baseline (Figure 1), demonstrating a potential dose: response relationship between vitamin A levels and multimorbidity.

Table 1

Main demographic, social and clinical characteristics of the studied subjects. Categorical variables are reported as frequencies (%), and continuous variables are reported as medians (interquartile ranges).

N = 500
Age (years)60.7 (48.4 to 71.9)
Male gender202 (40.4)
BMI (Kg/m2)25.0 (22.4 to 28.0)
Living region
North Italy362 (72.4)
Central Italy88 (17.6)
South Italy50 (10.0)
Job type
Stable employment164 (32.9)
Occasional work60 (12.0)
Not working101 (20.2)
Student13 (2.6)
Retired161 (32.3)
Education level
Primary school109 (21.8)
Middle school186 (37.2)
High school151 (30.2)
College54 (10.8)
Presence of cancer38 (7.6)
CAD27 (5.4)
History of stroke11 (2.2)
Presence of diabetes55 (11)
Respiratory diseases28 (5.6)
Arterial hypertension173 (34.6)
Osteoporosis86 (17.2)
Active smoking86 (17.2)

BMI: body mass index; CAD: coronary artery disease.

Table 2

Baseline main biochemical parameters and serum vitamin levels of the studied subjects. The variables are reported as medians (interquartile ranges).

N = 500
Hemoglobin (g/dL)13.8 (13.0 to 14.7)
MCV (fL)91.2 (88.5 to 94.4)
Platelets (n * 1000/mL)222 (190 to 258)
WBCs (n * 1000/mL)6.01 (4.99 to 7.26)
Creatinine (mg/dL)0.88 (0.77 to 1.00)
Uric acid (mg/dL)4.6 (3.8 to 5.6)
Ca (mMol/L)2.36 (2.30 to 2.43)
P (mMol/L)1.07 (0.95 to 1.19)
iPTH (pg/mL)57.6 (43.5 to 78.5)
25-OH-vitamin D (ng/mL)20.4 (14.0 to 26.1)
Vitamin A (μg/L)654 (550 to 771)
Vitamin E (mg/L)11.3 (8.2 to 14.1)

MCV: mean corpuscular volume; WBCs: white blood cells; Ca: serum calcium, P: serum phosphorus; iPTH: serum parathormone.

Table 3

Vitamin D, vitamin A, and vitamin E serum concentrations in relation to demographic, clinical, and biochemical parameters in the studied population. Spearman’s rank correlation coefficient rho (r) was calculated and is presented.

25-OH-Vitamin D25-OH-Vitamin D
(Corrected for Season)
Vitamin AVitamin E
Corr. Coeff.
ρ
p Corr. Coeff.
ρ
p Corr. Coeff.
ρ
p Corr. Coeff.
ρ
p
Age (years)−0.2010<0.001−0.1533<0.0010.07880.07850.2785<0.001
Gender (f = 0/m = 1)−0.00300.94650.00650.88430.2023<0.001−0.00150.9726
Living region
North Italy (0)
Central Italy (1)
South Italy (2)
0.1950<0.0010.05280.2383−0.08880.0472−0.4578<0.001
Education (0 = primary, 1 = middle, 2 = high, or 3 = university)0.07760.08290.07060.1148−0.01850.6806−0.12020.0071
Job (0 = no, 1 = occasional, 2 = stable, 3 = retired, or 4= student)−0.04300.33730.00070.9878−0.00730.87130.07330.1017
BMI (Kg/m2)−0.03980.3743−0.03300.46210.2157<0.0010.03510.4336
Smoking (no = 0/y = 1)0.02150.63090.01880.67440.12430.0054−0.02770.5360
Creatinine (mg/dL)−0.05060.2589−0.01380.75840.3098<0.0010.06620.1395
Uric acid (mg/dL)−0.03340.4556−0.01770.69370.3186<0.0010.05600.2115
Ca (mMol/L)0.07810.08120.07550.09160.2133<0.0010.06010.1796
P (mMol/L)0.05950.18410.01640.7143−0.08460.05870.02810.5301
iPTH (pg(mL)−0.3407<0.001−0.3007<0.001−0.10300.02120.13660.0022
iPTH (pg(mL) season-corrected)−0.3303<0.001−0.3072<0.001−0.10600.01780.11530.0099
WBCs (n * 1000/mL)−0.00460.9174−0.01220.78510.2702<0.001−0.03790.3977
Hemoglobin (g/dL)0.02090.64120.06140.17050.2386<0.0010.1480<0.001
Platelets (n * 1000/mL)0.0840.06580.12830.00410.1489<0.0010.1793<0.001

BMI: body mass index; WBCs: white blood cells; Ca: serum calcium, P: serum phosphorus; iPTH: serum parathormone.

Table 4

25-OH-vitamin D, vitamin A and vitamin E serum concentrations in relation to the presence of diseases evaluated in the studied population. Medians (interquartile ranges) and rank-sum test (Mann: Whitney) comparisons are presented.

25-OH-Vitamin D
(ng/mL)
Vitamin A
(mg/L)
Vitamin E
(mg/L)
PresentAbsent p PresentAbsent p PresentAbsent p
Osteoporosis
(N = 107)
18.1
(11.6 to 25.6)
21.1
(14.9 to 26.2)
0.0146670
(570 to 800)
645
(544 to 766)
0.060118.1
(11.6 to 25.6)
11.0
(7.8 to 13.8)
0.0082
Arterial hypertension
(N = 173)
19.2
(12.8 to 25.1)
21.1
(15.0 to 26.4)
0.0473670
(570 to 808)
647
(532 to 758)
0.004711.8
(9.0 to 14.3)
10.8
(7.8 to 14.0)
0.0846
Diabetes
(N = 55)
22.3
(13.5 to 28.3)
20.2
(14.1 to 26.0)
0.2715693
(551 to 905)
650
(548 to 763)
0.036311.2
(7.6 to 13.7)
11.3
(8.4 to 14.2)
0.4409
Respiratory diseases
(N = 28)
18.8
(12.4 to 24.5)
20.5
(14.3 to 26.4)
0.1115621
(501 to 744)
656
(554 to 772)
0.318810.8
(9.2 to 12.3)
11.4
(8.1 to 14.3)
0.5902
CAD
(N = 27)
13.7
(8.7 to 23.7)
20.6
(14.6 to 26.3)
0.0017625
(538 to 733)
655
(551 to 772)
0.363511.0
(8.4 to 13.6)
11.3
(8.2 to 14.1)
0.6787
History of stroke
(N = 11)
20.0
(12.8 to 31.8)
20.5
(14.1 to 26.1)
0.9470745
(518 to 870)
625
(551 to 770)
0.28009.0
(7.6 to 12.3)
11.4
(8.2 to 14.2)
0.1102
Presence of cancer
(N = 38)
16.7
(12.4 to 24.3
20.5
(14.4 to 26.2)
0.1387727
(574 to 880)
650
(545 to 763)
0.010112.1
(9.6 to 14.1)
11.2
(8.1 to 14.1)
0.1743

CAD: coronary artery disease.

Table 5

Association between demographic, clinical, and biochemical parameters, and presenting at baseline one or less (N = 412) versus more than one (two to five) chronic disease (N = 88) in the studied population. Spearman’s rank correlation rho was calculated and presented in the univariate analysis. Stepwise logistic regression with a forward approach was used to discriminate variables independently associated with the presence of two or more diseases.

Presence of >1 Diseases at Baseline
Univariate AnalysisMultivariate Logistic
Regression Analysis
ρ p OR95% CI p
Age (years)0.32130.00001.0681.047 to 1.089<0.001
Gender (f = 0/m = 1)0.24030.00002.2591.330 to 3.8370.003
Living region
North Italy (0)
Central Italy (1)
South Italy (2)
−0.14460.0012Not reportedNot reportedNot reported
Education (0 = primary, 1 = middle, 2 = high, or 3 = university)−0.23780.0000Not reportedNot reportedNot reported
Job (0 = no, 1 = occasional, 2 = stable, 3 = retired, or 4= student)0.13230.0030Not reportedNot reportedNot reported
BMI (Kg/m2)0.21630.00001.0691.010 to 1.1310.021
Smoking (no = 0/y = 1)−0.02970.5072
Creatinine (mg/dL)0.19670.0000Not reportedNot reportedNot reported
Uric acid (mg/dL)0.24010.0000Not reportedNot reportedNot reported
Ca (mMol/L)0.02320.6052
P (mMol/L)−0.11130.0127
iPTH (pg/mL)0.06540.1441
WBCs (n * 1000/mL)0.01260.7785
Hemoglobin (g/dL)0.00750.8666
Platelets (n * 1000/mL)−0.06330.1578
25-OH-vitamin D (ng/mL)−0.07950.0758Not reportedNot reportedNot reported
Vitamin A (mg/L)0.14030.00171.0031.001 to 1.131<0.001
Vitamin E (mg/L)0.02400.5919

BMI: body mass index; WBCs: white blood cells; Ca: serum calcium, P: serum phosphorus; iPTH: serum parathormone.

Table 6

Association between demographic, clinical, and biochemical parameters (N = 500), with the presence of cancer at baseline in the studied population. Spearman’s rank correlation rho was calculated and presented in univariate analysis. Stepwise regression with a forward approach was used to discriminate variables independently associated with the presence of cancer.

Presence of Cancer (N = 38)
Univariate AnalysisMultivariate Logistic
Regression Analysis
ρ p OR95% CI p
Age (years)0.16910.00011.0441.019 to 1.069<0.001
Gender (f = 0/m = 1)0.10230.0222Not reportedNot reportedNot reported
Living region
North Italy (0)
Central Italy (1)
South Italy (2)
−0.10570.0181Not reportedNot reportedNot reported
Education (0 = primary, 1 = middle, 2 = high, or 3 = university)−0.04590.3054
Job (0 = no, 1 = occasional, 2 = stable, 3 = retired, or 4= student)0.05750.1991
BMI (Kg/m2)0.06490.1472
Smoking (no = 0/y = 1)−0.09070.0426Not reportedNot reportedNot reported
Creatinine (mg/dL)0.08840.0482Not reportedNot reportedNot reported
Uric acid (mg/dL)0.10170.0230Not reportedNot reportedNot reported
Ca (mMol/L)−0.02700.5462
P (mMol/L)−0.03340.4556
iPTH (pg/mL)−0.00550.9030
WBCs (n * 1000/mL)−0.02210.6217
Hemoglobin (g/dL)−0.01850.6796
Platelets (n * 1000/mL)−0.00550.9021
25-OH-vitamin D (ng/mL)−0.06630.1389
Vitamin A (mg/L)0.11510.01001.0021.000 to 1.0040.014
Vitamin E (mg/L)0.06080.1746

BMI: body mass index; WBCs: white blood cells; Ca: serum calcium, P: serum phosphorus; iPTH: serum parathormone.

Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results

Conclusions

In conclusion, this study demonstrates that vitamin D insufficiency is highly prevalent in Italian general practice populations, affecting most surveyed individuals with a median concentration below recommended thresholds. Although vitamin A concentrations were within normal ranges on average, they showed significant and independent associations with multiple chronic diseases and comorbidities, including cancer, diabetes mellitus, and arterial hypertension. The specific relationship between elevated vitamin A and multimorbidity suggests complex metabolic interactions that warrant further investigation through prospective cohort studies and mechanistic research.

Vitamin E showed limited associations with clinical outcomes in this population, consistent with recent trial evidence [14] questioning its clinical utility for chronic disease prevention. These findings highlight the importance of comprehensive vitamin status assessment in primary care settings and suggest that vitamin A metabolism may represent an underappreciated marker of metabolic health and disease burden. Future prospective studies with repeated measurements, detailed dietary and supplement data, assessment of genetic variants affecting vitamin metabolism, and mechanistic investigations are needed to clarify the causal relationships between vitamin status and chronic disease development, ultimately informing evidence-based screening and intervention strategies in general practice populations.

In the meantime, it remains of paramount importance to strictly adhere to dietary guidelines, avoiding a delayed implementation of existing intervention strategies, when the current results do not indicate any deficiencies in them.

Source: 5. Conclusions Source: 5. Conclusions
Authors’ abstract

Background: Vitamin deficiencies remain prevalent worldwide and contribute to chronic disease burden. This study evaluated serum concentrations of vitamins D, A, and E in Italian general practice populations and examined their associations with prevalent chronic diseases. Methods: This multicenter cross-sectional study enrolled 500 adult patients (median age: 60.7 years; 40.4% male) attending 21 general practice offices across Italy between January 2021 and December 2024. Serum concentrations of 25-hydroxyvitamin D [25(OH)D], vitamin A, and vitamin E were measured alongside demographic, clinical, and biochemical parameters.

Statistical analyses included chi-square tests, correlation analyses, and stepwise logistic regression. Results: The median 25(OH)D concentration was 20.4 ng/mL, below optimal levels. Vitamin D deficiency was significantly associated with osteoporosis (p = 0.015), arterial hypertension (p = 0.047), and coronary artery disease (p = 0.002). The median vitamin A (654 μg/L) and vitamin E (11.3 mg/L) concentrations were within normal ranges. Notably, elevated vitamin A levels were significantly associated with arterial hypertension (p = 0.005), diabetes mellitus (p = 0.036), and cancer (p = 0.010).

In the multivariate analysis, elevated vitamin A levels emerged as an independent predictor of multiple comorbidities (p < 0.001) and cancer presence (p = 0.014), alongside age, male gender, and body mass index. Conclusions: Vitamin D insufficiency is highly prevalent in Italian primary care populations. Vitamin A concentrations show independent associations with multimorbidity and cancer, suggesting a potential negative influence of an animal-based diet, warranting prospective investigation. These findings highlight the importance of comprehensive vitamin assessment in general practice settings.

Read the full paper

1. Introduction

Vitamins are essential micronutrients that play critical roles in maintaining human health and preventing chronic diseases. Among fat-soluble vitamins, vitamins D, A, and E have been extensively studied for their diverse biological functions, including immunomodulation, antioxidant activity, and cellular differentiation [1,2,3]. Despite their well-established importance, vitamin deficiencies remain prevalent worldwide, contributing to increased morbidity and mortality from chronic non-communicable diseases [4,5].

Vitamin D, primarily recognized for its role in calcium homeostasis and bone metabolism, has emerged as a crucial regulator of multiple physiological processes beyond skeletal health [6,7]. Observational studies have consistently demonstrated an inverse association between vitamin D status and the risk of major chronic diseases, including type 2 diabetes, cardiovascular disease, and cancer [8,9,10]. Recent evidence from large-scale epidemiological studies indicates that vitamin D deficiency affects an estimated 50% or more of populations in both developed and developing countries, with a particularly high prevalence among older adults and specific ethnic groups [2,11].

The 2024 Endocrine Society Clinical Practice Guidelines have updated recommendations for vitamin D assessment and supplementation, emphasizing the need for targeted interventions in high-risk populations while recognizing ongoing debates regarding optimal serum levels and universal supplementation strategies [12,13].

Vitamin A, encompassing both preformed retinol and provitamin A carotenoids, is essential for vision, immune function, cellular differentiation, and epithelial integrity [14,15]. While severe vitamin A deficiency has been largely eradicated in developed countries through food fortification programs, subclinical deficiency and, conversely, excessive intake remain areas of clinical concern [16]. The relationship between vitamin A status and chronic disease exhibits complexity, with both deficiency and excess potentially associated with adverse health outcomes [17,18].

Recent systematic reviews and meta-analyses have revealed mixed findings regarding the association between vitamin A intake or serum levels and cancer risk, with some studies suggesting protective effects for certain malignancies, while others indicate potential harm, particularly in specific populations such as smokers receiving high-dose beta-carotene supplementation [19,20,21]. Furthermore, emerging evidence suggests that elevated serum vitamin A levels may be associated with metabolic dysfunction and chronic inflammatory states, although the directionality of this relationship: whether causative or consequential: remains unclear [22,23,24].

Vitamin E, comprising eight naturally occurring isomers (four tocopherols and four tocotrienols), functions primarily as a lipophilic antioxidant protecting cellular membranes from oxidative damage [25]. Alpha-tocopherol, the most biologically active form, has been studied extensively for its potential role in preventing cardiovascular disease, cancer, and neurodegenerative disorders [26,27]. However, despite compelling biological mechanisms and promising observational data, large randomized controlled trials have generally failed to demonstrate consistent clinical benefits of vitamin E supplementation for chronic disease prevention [28,29].

Recent meta-analyses examining vitamin E anti-inflammatory properties have shown modest reductions in inflammatory biomarkers such as C-reactive protein and interleukin-6, particularly at higher supplementation doses, yet translation of these effects into clinically meaningful outcomes remains elusive [30]. The European Food Safety Authority’s 2024 scientific opinion on tolerable upper intake levels for vitamin E has reinforced concerns about potential adverse effects, particularly increased bleeding risk, emphasizing the importance of understanding both deficiency and excess states in clinical populations [31].

The interplay between vitamin status and chronic disease development is further complicated by multiple factors, including genetic polymorphisms affecting vitamin metabolism, concurrent medications, dietary patterns, and comorbid conditions that alter absorption and utilization [32,33]. Moreover, the metabolic relationships among different vitamins and their roles in shared pathophysiological pathways suggest that assessment of multiple vitamin status simultaneously may provide more comprehensive insights into disease risk than evaluation of individual vitamins in isolation [34].

General practice settings represent an ideal environment for evaluating vitamin status in community-dwelling adults, as general practitioners serve as first-line healthcare providers with access to diverse patient populations across a wide age spectrum. However, limited data exist regarding the distribution of vitamin D, A, and E concentrations in primary care populations and their associations with common chronic comorbidities encountered in clinical practice.

Therefore, this cross-sectional cohort study aimed to evaluate serum concentrations of vitamins D, A, and E in a cohort of adult patients attending general practice offices throughout Italy, and to examine the associations between these vitamin levels and prevalent chronic diseases, including cardiovascular disease, diabetes mellitus, osteoporosis, and malignancy. By characterizing vitamin status and its clinical correlates in this population, we sought to identify patterns that might inform screening strategies and preventive interventions in primary care settings.

2. Materials and Methods

2.1. Study Protocol

This multicenter cross-sectional cohort study was conducted in collaboration with general practitioners (GPs) across Italy. The study protocol was proposed to multiple GPs working in Northern, Central, and Southern Italy through the Italian GP Federation. Following protocol review, 21 Italian GPs (18 from Northern Italy, 2 from Central Italy, and 1 from Southern Italy) agreed to participate in this study. The protocol was approved by the Internal Review Board of the University of Udine and conducted in accordance with the Declaration of Helsinki.

Each enrolled patient provided written informed consent, which was administered by their respective GP. Serum vitamins level measurements and determination of cut-off values of normality were performed in all the laboratories referring to GPs areas following these methods: for 25-OH-vitamin D, by an immunoassay method (<10 ng/mL: deficiency, 10 to 30: insufficiency, and >30: sufficiency) [2]; for vitamin A, by a reversed-phase HPLC method focused on a retinol-only form (normal values: 300 to 800 microg/L); and vitamin E, by alpha-tocopherol (normal values: 5.5 to 18 mg/L) [35].

2.2. Study Population

The study population comprised adult subjects aged 18 to 70 years attending the offices of the 18 participating Italian GPs between 1 January 2021 and 31 December 2024. Each GP identified among his patients who did not report taking any vitamin supplements, those in whom at least one measurement of serum vitamins D, A, and E was available during this period. Vitamin measurements may have been performed for specific clinical indications or proposed by the GP as part of a routine health assessment.

For each enrolled patient, additional laboratory parameters were collected, including serum levels of parathyroid hormone (iPTH), calcium, phosphorus, uric acid, and creatinine.

After anonymization using numerical codes assigned by each participating GP, the following data were systematically collected from practice management systems: date of data collection, GP identification details, patient demographic characteristics (region of residence, gender, age, and ethnicity, categorized as Caucasian or other), anthropometric measurements (body mass index, calculated as weight in kilograms divided by height in meters squared), occupational status (employed, casual work, unemployed, student, or retired), educational attainment (primary school, middle school, high school, or university (college) degree), smoking history (never, past, or current smoker), and presence of chronic diseases, including malignancy (active or past), cardiovascular disease, stroke, diabetes mellitus, arterial hypertension, respiratory disease, and osteoporosis.

All clinical diagnoses and demographic information reflected the status recorded in the patient file at the time of enrollment. Patient age was calculated from the enrollment date.

2.3. Data Management

Each participating GP entered the collected data into a standardized Microsoft Excel spreadsheet, with each row representing an individual patient code and each column representing a specific variable. Upon completion of data entry, patient records remained in the possession of the individual GP responsible for patient care. For statistical analysis purposes, only anonymized datasets were transmitted to the study statistician.

2.4. Statistical Analysis

Statistical analysis was performed using the Stata 15.1 statistical software (StataCorp, 2017; Stata Statistical Software: Release 15; College Station, TX, USA: StataCorp LLC). Categorical variables were expressed as absolute numbers and percentages, while continuous variables were presented as median values with interquartile ranges. Associations between categorical variables were evaluated using the chi-square test, with the test for linear trend applied when appropriate. The Spearman nonparametric test was used to correlate variables, and the Mann: Whitney test was used to compare the values of vitamins in patients with or without disease.

Stepwise logistic regression analysis was utilized to identify independent predictors of vitamins D, A, and E deficiency. A two-tailed p-value of less than 0.05 was considered statistically significant.

3. Results

Subjects: Five hundred subjects were enrolled in this study. The principal demographic, social, and clinical characteristics of the study population are presented in Table 1. The median age was 60.7 years, and 40.4% of participants were male. Most patients resided in Northern Italy (72.4%), 17.6% were from Central Italy, and 10.0% were from Southern Italy. Approximately 40% were actively employed, while 32.3% were retired. More than half of the enrolled patients had attained higher educational levels, having completed middle school (37.2%) or high school education (30.2%).

Nearly one-third of patients had a diagnosis of arterial hypertension, 11.0% had diabetes mellitus, 17.2% had osteoporosis, 7.6% had cancer, 5.4% had coronary artery disease (CAD), and approximately 17.2% were current smokers.

The principal laboratory parameters evaluated at enrollment, including serum concentrations of 25-hydroxyvitamin D [25(OH)D], vitamin A, and vitamin E, are described in Table 2. Regarding vitamin status, only the median 25(OH)D concentration (20.4 ng/mL) fell below the optimal range, whereas median serum concentrations of both vitamin A (654 μg/L) and vitamin E (11.3 mg/L) were within normal reference ranges.

3.1. Associations Between Vitamin Concentrations and Clinical Parameters

Table 3 presents the relationships between serum concentrations of vitamins D, A, and E and the principal demographic, clinical, and laboratory parameters.

25-Hydroxyvitamin D: A statistically significant inverse correlation was observed between age and serum 25(OH)D concentrations (p < 0.001), which persisted after adjustment for the season in which vitamin D measurement was performed (winter versus summer) (p < 0.001). Conversely, the initial significant association between 25(OH)D concentrations and Italian geographic region of residence (p < 0.001) was no longer significant following seasonal correction (p = 0.238). A significant inverse correlation between 25(OH)D levels and serum PTH was documented (p < 0.001), remaining significant after seasonal adjustment (p < 0.001).

Among social and biochemical parameters, a significant positive correlation was identified between 25(OH)D concentrations and platelet count (p = 0.066 before seasonal correction; p = 0.004 after seasonal correction).

Vitamin A: Significant positive correlations were found between vitamin A serum concentrations and male gender (p < 0.001), body mass index (p < 0.001), serum creatinine (p < 0.001), serum uric acid (p < 0.001), serum calcium (p < 0.001), white blood cell count (p < 0.001), hemoglobin concentration (p < 0.001), and platelet count (p < 0.001).

Vitamin E. Significant positive correlations were observed between vitamin E serum concentrations and age (p < 0.001), Italian geographic region of residence (p < 0.001), serum PTH (p = 0.002): which remained significant after seasonal correction (p = 0.009): as well as hemoglobin concentration (p < 0.001) and platelet count (p < 0.001).

3.2. Vitamin Concentrations and Clinical Diseases

Table 4 presents the correlations between serum concentrations of vitamins D, A, and E and the clinical characteristics of the study population.

Vitamin D: Median serum 25(OH)D concentrations were significantly lower in patients with osteoporosis compared with those without (18.1 vs. 21.1 ng/mL; p = 0.015), in patients with arterial hypertension versus those without (19.2 vs. 21.1 ng/mL; p = 0.047), and in patients with CAD versus those without (13.7 vs. 20.6 ng/mL; p = 0.002).

Vitamin A: Significantly elevated median serum vitamin A concentrations were observed in patients with arterial hypertension compared with those without (670 vs. 647 μg/L; p = 0.005), in patients with diabetes mellitus versus those without (693 vs. 650 μg/L; p = 0.036), and in patients with cancer versus those without (727 vs. 650 μg/L; p = 0.010). Patients with vitamin A over 800 μg/L have a higher cancer presence (15/102 [14.7%] vs. 23/398 [5.8%]; p = 0.002).

Vitamin E: The only statistically significant correlation was higher vitamin E serum concentrations in patients presenting osteoporosis compared with those who did not (18.1 vs. 11.0 mg/L; p = 0.008).

Table 5 displays the univariate and multivariate analyses examining independent predictors of having no or one (N = 412) or more (N = 88) baseline clinical diseases in the study population. In univariate analysis, age (p < 0.001), male gender (p < 0.001), living region (p = 0.001), education level (p < 0.001), job (p = 0.003), BMI (p < 0.001), creatinine (p < 0.001), uric acid (p < 0.001), phosphorus (p = 0.0127), and vitamin A (p = 0.002) were significantly associated with multiple chronic diseases.

In multivariate analysis, independent predictors of having multiple clinical diseases included older age (p < 0.001), male gender (p = 0.003), increased BMI (p = 0.021), and elevated serum vitamin A concentrations (p < 0.001). A linear trend was detected between the number of patients with a vitamin A serum concentration above the upper limit and the presence of one or more chronic diseases (no disease= 16.3%, one = 19.7%, and two or more = 27.3%; linear trend p < 0.001 Supplementary Figure S1).

Furthermore, as shown in Table 6, elevated vitamin A serum concentrations, in addition to older age, emerged as independent predictors of prevalent cancer at baseline in the multivariate analysis. In the univariate analysis, age (p < 0.001), male gender (p = 0.022), living region (p = 0.018), creatinine (p = 0.048), uric acid (p = 0.023), and vitamin A (p = 0.010) were associated with cancer presence. In the multivariate model, only age (p < 0.001) and vitamin A (p = 0.014) remained as independent predictors.

Additionally, a progressive increase in vitamin A serum concentrations was significantly associated with an increasing number of chronic diseases present at baseline (Figure 1), demonstrating a potential dose: response relationship between vitamin A levels and multimorbidity.

4. Discussion

This cross-sectional cohort study examined serum concentrations of vitamins D, A, and E in a cohort of 500 adult subjects attending general practice offices throughout Italy, along with their associations with demographic characteristics, clinical comorbidities, and biochemical parameters. Our findings reveal distinct patterns for each vitamin, with important clinical and public health implications.

Regarding 25(OH)D, our results demonstrated that median serum concentrations (20.4 ng/mL) fell below the optimal range, consistent with the widespread vitamin D insufficiency reported in European and global populations [2,11]. The inverse correlation between vitamin D concentrations and age observed in our study aligns with previous literature demonstrating age-related decline in vitamin D status attributable to reduced cutaneous synthesis, decreased renal hydroxylation capacity, and diminished outdoor activity among older adults [6,7]. Importantly, this association persisted after seasonal correction, suggesting that age-related factors beyond sun exposure contribute to vitamin D deficiency.

The inverse relationship between 25(OH)D and parathyroid hormone concentrations confirms the well-established negative feedback mechanism in calcium: phosphate homeostasis [13,32].

Our findings of significantly lower vitamin D concentrations in patients with osteoporosis, arterial hypertension, and coronary artery disease are consistent with extensive epidemiological evidence linking vitamin D deficiency to multiple chronic conditions [8,9,10]. This evidence could be reinforced considering that a patient with chronic disease spends more time indoors than a healthy person, thus reducing the self-synthesis of vitamin D during sun exposure [36]. The association with osteoporosis is well documented, as vitamin D plays a crucial role in calcium absorption and bone metabolism [33,34].

Recent meta-analyses have confirmed that combined calcium and vitamin D supplementation modestly improves bone mineral density and may reduce fracture risk in postmenopausal women with osteoporosis, although the magnitude of benefit remains subject to debate [37,38]. The relationship with cardiovascular diseases, including hypertension and coronary artery disease, supports the hypothesis that vitamin D exerts pleiotropic effects beyond skeletal health, potentially through modulation of the renin: angiotensin: aldosterone system, endothelial function, and inflammatory pathways [9,10].

However, the 2024 Endocrine Society guidelines acknowledge that despite compelling observational associations, most randomized controlled trials have failed to demonstrate clear clinical benefits of vitamin D supplementation for cardiovascular disease prevention in the general population [12]. These findings underscore the importance of monitoring vitamin D status in populations at risk for these conditions while recognizing the complexity of translating observational associations into effective interventions.

The vitamin A findings present a more complex and clinically intriguing picture. While median serum concentrations were within the normal range (654 μg/L), we observed significantly elevated concentrations in patients with arterial hypertension, diabetes mellitus, and cancer. The positive correlations between vitamin A concentrations and male gender, BMI, creatinine, uric acid, and hematological parameters suggest that vitamin A metabolism may be influenced by metabolic and inflammatory status [22,23,24]. Most notably, elevated vitamin A emerged as an independent predictor of both multiple comorbidities and cancer presence at baseline, even after adjustment for age, gender, and BMI.

This finding requires careful interpretation, as the relationship between vitamin A and chronic diseases exhibits a U-shaped curve, with both deficiency and excess being potentially harmful [17,18]. The association between elevated vitamin A concentrations and cancer deserves particular attention and warrants mechanistic investigation. While vitamin A and its metabolites have traditionally been considered protective against carcinogenesis through their roles in cellular differentiation and immune function [14,15], recent evidence suggests that excessive vitamin A intake or elevated serum retinol concentrations may paradoxically increase cancer risk in certain populations [19,20,21].

Our observation that vitamin A concentrations progressively increased with the number of chronic diseases suggests that elevated vitamin A may serve as a biomarker of underlying metabolic dysfunction or chronic inflammatory states rather than a causative factor. Alternatively, reverse causation cannot be excluded, as chronic diseases may alter vitamin A metabolism, distribution, and clearance. The documented association between vitamin A and metabolic syndrome components, including insulin resistance and adiposity, provides a potential mechanistic link [39,40,41].

The positive correlations between vitamin A and markers such as creatinine, uric acid, and metabolic parameters may reflect hepatic and renal function alterations, as both organs play critical roles in vitamin A metabolism [22]. The liver stores approximately 80 to 90% of total body vitamin A as retinyl esters, and impaired hepatic or renal function can lead to altered vitamin A homeostasis [23]. Furthermore, insulin resistance and metabolic syndrome, conditions commonly associated with the comorbidities observed in our population, have been linked to altered retinoid metabolism and elevated circulating retinol-binding protein 4 (RBP4), which has emerged as an adipokine implicated in insulin resistance [39,40,41].

A further potential explanation of our findings is to consider that vitamin A per se cannot be the primary factor in determining the increased risk of chronic disease and cancer, but that products present in drinks or foods containing vitamin A may have a relevant role. There are two types of dietary sources of vitamin A: either plant foods containing β-carotene or animal foods containing retinyl esters. It has been shown that the conversion of β-carotene to retinol is under negative-feedback control, since a high vitamin A status inhibits the formation of the rate-limiting enzyme of this conversion [42,43].

This limits the level of retinol in the plasma, even if only part of the dietary vitamin A comes from plant sources. Thus, elevated vitamin A status is only possible if the animal foods in the diet provide an excess of the required retinol. However, the association between high vitamin A serum levels and diseases could be caused either by the vitamin A itself, by anything harmful that occurs primarily in animal-based foods, such as saturated fats or nitrosamines, or by a deficiency of something that does not primarily occur in animal-based food, such as fiber or phytochemicals [44].

The vitamin E results demonstrated a positive correlation with age and PTH concentrations, but, notably, no significant associations were found with clinical comorbidities besides osteoporosis. Vitamin E serum concentrations are regulated by a negative-feedback mechanism, ensuring that the plasma status matches the requirements [45]. Older people, particularly those with osteoporosis, may require more vitamin E to maintain the oxidative balance in their cells than people who do not have these risk factors. In this case, the high vitamin E serum levels would be a marker of oxidative dysfunction, rather than a cause of it [46].

The modest positive correlation between vitamin E and hematological parameters (hemoglobin and platelet counts) may also reflect the antioxidant role of vitamin E in protecting blood cells from oxidative damage [25], although this association lacks clinical significance in the absence of correlations with clinical endpoints. The lack of meaningful associations between vitamin E and chronic diseases contrasts with some earlier observational studies suggesting protective effects of vitamin E against cardiovascular disease and certain cancers [26,27].

However, our findings align with more recent large-scale randomized controlled trials that have failed to demonstrate clear clinical benefits of vitamin E supplementation in chronic disease prevention [28,29]. The ATBC trial and subsequent studies revealed either no benefit or potential harm from high-dose vitamin E supplementation [28].

The multivariate analysis identifying older age, male gender, elevated BMI, and elevated vitamin A concentrations as independent predictors of multiple comorbidities highlights the interconnected nature of metabolic health and vitamin status. The specific association between vitamin A and multimorbidity, independent of other traditional risk factors, suggests that vitamin A metabolism may be more intimately linked to systemic metabolic dysfunction than previously recognized. This finding warrants prospective studies to determine whether elevated vitamin A represents a consequence of chronic disease, a contributor to disease progression, or both.

Given the observational nature of our study, we cannot establish causality, and the observed association may reflect confounding by unmeasured factors or reverse causation.

Several limitations of this study merit consideration. First, the cross-sectional design precludes causal inferences regarding the relationships between vitamin concentrations and chronic diseases. Prospective longitudinal studies are needed to establish temporal relationships and determine whether vitamin status predicts disease incidence or represents a consequence of existing disease. Second, the study population was predominantly drawn from Northern Italy, potentially limiting generalizability to other geographic regions or ethnic groups with different dietary patterns, sun exposure, and genetic backgrounds. Third, single-point measurements of vitamin concentrations may not accurately reflect long-term vitamin status, and seasonal variations in vitamin D, despite statistical adjustments, remain a potential source of bias.

Finally, residual confounding from unmeasured variables, such as physical activity levels and genetic factors affecting vitamin metabolism, cannot be entirely excluded despite multivariate adjustment.

Despite these limitations, our study has several notable strengths. The relatively large sample size (n = 500) and inclusion of multiple sites across different Italian regions enhance the representativeness of our findings for primary care populations. The simultaneous assessment of three distinct vitamins provides a more comprehensive picture of vitamin status than studies focusing on individual vitamins. Additionally, the inclusion of diverse clinical and laboratory parameters, including hematological indices, renal function markers, and metabolic parameters, allowed for extensive exploration of potential associations and confounding factors.

5. Conclusions

In conclusion, this study demonstrates that vitamin D insufficiency is highly prevalent in Italian general practice populations, affecting most surveyed individuals with a median concentration below recommended thresholds. Although vitamin A concentrations were within normal ranges on average, they showed significant and independent associations with multiple chronic diseases and comorbidities, including cancer, diabetes mellitus, and arterial hypertension. The specific relationship between elevated vitamin A and multimorbidity suggests complex metabolic interactions that warrant further investigation through prospective cohort studies and mechanistic research.

Vitamin E showed limited associations with clinical outcomes in this population, consistent with recent trial evidence [14] questioning its clinical utility for chronic disease prevention. These findings highlight the importance of comprehensive vitamin status assessment in primary care settings and suggest that vitamin A metabolism may represent an underappreciated marker of metabolic health and disease burden. Future prospective studies with repeated measurements, detailed dietary and supplement data, assessment of genetic variants affecting vitamin metabolism, and mechanistic investigations are needed to clarify the causal relationships between vitamin status and chronic disease development, ultimately informing evidence-based screening and intervention strategies in general practice populations.

In the meantime, it remains of paramount importance to strictly adhere to dietary guidelines, avoiding a delayed implementation of existing intervention strategies, when the current results do not indicate any deficiencies in them.

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/nu18060943/s1.

Supplement file at the original source: open the original paper. This file is not included in this text import.

Author Contributions

Conceptualization, P.B. and P.T.; methodology: E.F., P.B., P.T., A.C. (Annarosa Cussigh) and S.C.; software: E.F. and S.C.; validation: P.T., E.F. and P.B.; formal analysis: E.F., S.C. and P.T.; investigation: P.B., D.B., E.B., G.M.C., A.C. (Alberto Cannavino), N.C., F.C., C.C., P.F., R.F.N., G.F.C., F.F., L.G., P.M., G.M., C.N., I.P., H.R., A.R. and S.V.; resources: P.T. and S.C.; data curation: P.T., S.C. and E.F.; writing: original draft preparation,: P.T., S.C. and E.F.; writing: review and editing: E.F. and P.T.; visualization: E.F., S.C. and P.T.; supervision: P.T. and E.F.; project administration: P.B. and P.T.

All authors have read and agreed to the published version of the manuscript.

Institutional Review Board Statement

This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of the University of Udine, the Department of Medicine, on 22 January 2026 (protocol code IRB: 21/2026, Tit III cl 13 fasc. 22/2026).

Informed Consent Statement

Informed consent was obtained from all subjects involved in this study.

Data Availability Statement

The data presented in this study are available upon request from the corresponding author due to the privacy restrictions applied in our law.

Conflicts of Interest

The authors declare no conflicts of interest.

References

1. Ciarcia G. Bianchi S. Tomasello B. Acquaviva R. Malfa G.A. Naletova I. La Mantia A. Di Giacomo C. Vitamin E and Non-Communicable Diseases: A Review Biomedicines 2022 10 2473 10.3390/biomedicines10102473 36289735 PMC9599164
2. National Institutes of Health Vitamin D: Moving Toward Evidence-Based Decision Making in Primary Care National Institutes of HealthBethesda, MD, USA2014
3. Asbaghi O. Sadeghian M. Nazarian B. Sarreshtedari M. Mozaffari-Khosravi H. Maleki V. Alizadeh M. Shokri A. Sadeghi O. The effect of vitamin E supplementation on selected inflammatory biomarkers in adults: A systematic review and meta-analysis of randomized clinical trials Sci. Rep. 2020 10 17234 10.1038/s41598-020-73741-6 33057114 PMC7560744
4. Preuss C.V.K.A. King K.C. Vitamin D Deficiency StatPearlsTreasure Island, FL, USA2025
5. Goyal A. Terry M.B. Siegel A.B. Serum antioxidant nutrients, vitamin A, and mortality in U.S. Adults Cancer Epidemiol. Biomark. Prev. 2013 22 2202 2211 10.1158/1055-9965.EPI-13-0381 PMC4026170 23897583
6. Voulgaridou G. Papadopoulou S.K. Detopoulou P. Tsoumana D. Giaginis C. Kondyli F.S. Lymperaki E. Pritsa A. Vitamin D and Calcium in Osteoporosis, and the Role of Bone Turnover Markers: A Narrative Review of Recent Data from RCTs Diseases 2023 11 29 10.3390/diseases11010029 36810543 PMC9944083
7. Chen X. Shen L. Gao C. Weng R. Fan Y. Xu S. Zhang Z. Hu W. Vitamin D status and its associations with bone mineral density, bone turnover markers, and parathyroid hormone in Chinese postmenopausal women with osteopenia and osteoporosis Front. Nutr. 2023 10 1307896 10.3389/fnut.2023.1307896 38268673 PMC10806182
8. Zhao S. Qian F. Wan Z. Chen X. Pan A. Liu G. Vitamin D and major chronic diseases Trends Endocrinol. Metab. 2024 35 1050 1061 10.1016/j.tem.2024.04.018 38824035
9. Scragg R. Sowers M. Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey Am. J. Hypertens. 2007 20 713 719 10.1016/j.amjhyper.2007.01.017 17586404
10. Pittas A.G. Chung M. Trikalinos T. Mitri J. Brendel M. Patel K. Lichtenstein A.H. Lau J. Balk E.M. Systematic review: Vitamin D and cardiometabolic outcomes Ann. Intern. Med. 2010 152 307 314 10.7326/0003-4819-152-5-201003020-00009 20194237 PMC3211092
11. Reese J.A. Davis E. Fretts A.M. Ali T. Lee E.T. Umans J.G. Yarden R. Zhang Y. Peck J.D. Vitamin D Deficiency and Cardiovascular Disease Risk Factors Among American Indian Adolescents: The Strong Heart Family Study Prev. Chronic Dis. 2025 22 E13 10.5888/pcd22.240354 40179031 PMC11974461
12. Demay M.B. Pittas A.G. Bikle D.D. Diab D.L. Kiely M.E. Lazaretti-Castro M. Lips P. Mitchell D.M. Murad M.H. Powers S. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline J. Clin. Endocrinol. Metab. 2024 109 1907 1947 10.1210/clinem/dgae290 38828931
13. Holick M.F. Binkley N.C. Bischoff-Ferrari H.A. Gordon C.M. Hanley D.A. Heaney R.P. Murad M.H. Weaver C.M. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline J. Clin. Endocrinol. Metab. 2011 96 1911 1930 10.1210/jc.2011-0385 21646368
14. Talib W.H. Ahmed Jum A.D. Attallah Z.S. Jallad M.S. Al Kury L.T. Hadi R.W. Mahmod A.I. Role of vitamins A, C, D, E in cancer prevention and therapy: Therapeutic potentials and mechanisms of action Front. Nutr. 2023 10 1281879 10.3389/fnut.2023.1281879 38274206 PMC10808607
15. Stephensen C.B. Vitamin A, infection, and immune function Annu. Rev. Nutr. 2001 21 167 192 10.1146/annurev.nutr.21.1.167 11375434
16. Tanumihardjo S.A. Vitamin A: Biomarkers of nutrition for development Am. J. Clin. Nutr. 2011 94 658S 665S 10.3945/ajcn.110.005777 21715511 PMC3142734
17. Penniston K.L. Tanumihardjo S.A. The acute and chronic toxic effects of vitamin A Am. J. Clin. Nutr. 2006 83 191 201 10.1093/ajcn/83.2.191 16469975
18. Li H. Ye J. Dong Y. Kong W. Qian G. Xie Y. U-shaped association of serum vitamin A concentrations with all-cause mortality in patients with NAFLD: Results from the NHANES database prospective cohort study Front. Nutr. 2024 11 1467659 10.3389/fnut.2024.1467659 39539372 PMC11558463
19. Han X. Zhao R. Wang Y. Ma H. Yu M. Chen X. Zhang D. Ma S. Liu B. Cai H. Dietary Vitamin A Intake and Circulating Vitamin A Concentrations and the Risk of Three Common Cancers in Women: A Meta-Analysis Oxid. Med. Cell Longev. 2022 2022 7686405 10.1155/2022/7686405 36388168 PMC9646312
20. Omenn G.S. Goodman G.E. Thornquist M.D. Balmes J. Cullen M.R. Glass A. Keogh J.P. Meyskens F.L. Valanis B. Williams J.H. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease N. Engl. J. Med. 1996 334 1150 1155 10.1056/NEJM199605023341802 8602180
21. Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers N. Engl. J. Med. 1994 330 1029 1035 10.1056/NEJM199404143301501 8127329
22. Blomhoff R. Blomhoff H.K. Overview of retinoid metabolism and function J. Neurobiol. 2006 66 606 630 10.1002/neu.20242 16688755
23. Kawaguchi R. Yu J. Ter-Stepanian M. Zhong M. Cheng G. Yuan Q. Jin M. Travis G.H. Ong D. Sun H. Receptor-mediated cellular uptake mechanism that couples to intracellular storage ACS Chem. Biol. 2011 6 1041 1051 10.1021/cb200178w 21774515 PMC3199320
24. Bonet M.L. Ribot J. Palou A. Lipid metabolism in mammalian tissues and its control by retinoic acid Biochim. Biophys. Acta 2012 1821 177 189 10.1016/j.bbalip.2011.06.001 21669299
25. Traber M.G. Atkinson J. Vitamin E, antioxidant and nothing more Free Radic. Biol. Med. 2007 43 4 15 10.1016/j.freeradbiomed.2007.03.024 17561088 PMC2040110
26. Rimm E.B. Stampfer M.J. Ascherio A. Giovannucci E. Colditz G.A. Willett W.C. Vitamin E consumption and the risk of coronary heart disease in men N. Engl. J. Med. 1993 328 1450 1456 10.1056/NEJM199305203282004 8479464
27. Stampfer M.J. Hennekens C.H. Manson J.E. Colditz G.A. Rosner B. Willett W.C. Vitamin E consumption and the risk of coronary disease in women N. Engl. J. Med. 1993 328 1444 1449 10.1056/NEJM199305203282003 8479463
28. Miller E.R. 3rd Pastor-Barriuso R. Dalal D. Riemersma R.A. Appel L.J. Guallar E. Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality Ann. Intern. Med. 2005 142 37 46 10.7326/0003-4819-142-1-200501040-00110 15537682
29. Manson J.E. Cook N.R. Lee I.M. Christen W. Bassuk S.S. Mora S. Gibson H. Gordon D. Copeland T. D’Agostino D. Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease N. Engl. J. Med. 2019 380 33 44 10.1056/NEJMoa1809944 30415629 PMC6425757
30. Huang J. Weinstein S.J. Yu K. Mannisto S. Albanes D. Relationship Between Serum Alpha-Tocopherol and Overall and Cause-Specific Mortality Circ. Res. 2019 125 29 40 10.1161/CIRCRESAHA.119.314944 31219752 PMC8555690
31. EFSA Panel on Nutrition, Novel Foods and Food Allergens Turck D. Bohn T. Castenmiller J. de Henauw S. Hirsch-Ernst K. Knutsen H.K. Maciuk A. Mangelsdorf I. McArdle H.J. Scientific opinion on the tolerable upper intake level for vitamin E EFSA J. 2024 22 e8953 10.2903/j.efsa.2024.8953 39099617 PMC11294871
32. Reay W.R. Kiltschewskij D.J. Di Biase M.A. Gerring Z.F. Kundu K. Surendran P. Greco L.A. Clarke E.D. Collins C.E. Mondul A.M. Genetic influences on circulating retinol and its relationship to human health Nat. Commun. 2024 15 1490 10.1038/s41467-024-45779-x 38374065 PMC10876955
33. Bischoff-Ferrari H.A. Giovannucci E. Willett W.C. Dietrich T. Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes Am. J. Clin. Nutr. 2006 84 18 28 10.1093/ajcn/84.1.18 16825677
34. Vidal M. Ramana C.V. Dusso A.S. Stat1-vitamin D receptor interactions antagonize 1,25-dihydroxyvitamin D transcriptional activity and enhance stat1-mediated transcription Mol. Cell Biol. 2002 22 2777 2787 10.1128/MCB.22.8.2777-2787.2002 11909970 PMC133712
35. Cuesta Sanz D. Castro Santa-Cruz M. Simultaneous measurement of retinol and alpha-tocopherol in human serum by high-performance liquid chromatography with ultraviolet detection J. Chromatogr. 1986 380 140 144 10.1016/S0378-4347(00)83634-8 3745376
36. Chalcraft J.R. Cardinal L.M. Wechsler P.J. Hollis B.W. Gerow K.G. Alexander B.M. Keith J.F. Larson-Meyer D.E. Vitamin D Synthesis Following a Single Bout of Sun Exposure in Older and Younger Men and Women Nutrients 2020 12 2237 10.3390/nu12082237 32727044 PMC7468901
37. Liu C. Kuang X. Li K. Guo X. Deng Q. Li D. Effects of combined calcium and vitamin D supplementation on osteoporosis in postmenopausal women: A systematic review and meta-analysis of randomized controlled trials Food Funct. 2020 11 10817 10827 10.1039/D0FO00787K 33237064
38. Lei S. Zhang X. Song L. Wen J. Zhang Z. Tian J. Yang R. Xu S. Qiu S. MacIsaac R.J. Expert consensus on vitamin D in osteoporosis Ann. Jt. 2025 10 1 10.21037/aoj-24-48 39981430 PMC11836767
39. Blaner W.S. Vitamin A signaling and homeostasis in obesity, diabetes, and metabolic disorders Pharmacol. Ther. 2019 197 153 178 10.1016/j.pharmthera.2019.01.006 30703416 PMC6520171
40. Yang Q. Graham T.E. Mody N. Preitner F. Peroni O.D. Zabolotny J.M. Kotani K. Quadro L. Kahn B.B. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes Nature 2005 436 356 362 10.1038/nature03711 16034410
41. Al-Daghri N.M. Al-Attas O.S. Alokail M. Draz H.M. Bamakhramah A. Sabico S. Retinol binding protein-4 is associated with TNF-alpha and not insulin resistance in subjects with type 2 diabetes mellitus and coronary heart disease Dis. Markers 2009 26 135 140 10.1155/2009/725948 19597296 PMC3833337
42. Widjaja-Adhi M.A. Lobo G.P. Golczak M. Von Lintig J. A genetic dissection of intestinal fat-soluble vitamin and carotenoid absorption Hum. Mol. Genet. 2015 24 3206 3219 10.1093/hmg/ddv072 25701869 PMC4424956
43. Widjaja-Adhi M.A.K. Palczewski G. Dale K. Knauss E.A. Kelly M.E. Golczak M. Levine A.D. von Lintig J. Transcription factor ISX mediates the cross talk between diet and immunity Proc. Natl. Acad. Sci. USA 2017 114 11530 11535 10.1073/pnas.1714963114 29073082 PMC5664558
44. Tessier A.J. Wang F. Korat A.A. Eliassen A.H. Chavarro J. Grodstein F. Li J. Liang L. Willett W.C. Sun Q. Optimal dietary patterns for healthy aging Nat. Med. 2025 31 1644 1652 10.1038/s41591-025-03570-5 40128348 PMC12092270
45. Alanazi W. Allen C. Geary N. Marsh A. Brunstrom J.M. Rogers P.J. Mattes R.D. Berthoud H.-R. Provenza F. Leng G. How Micronutrient Status May Affect Eating Behavior-Hypothesis and Perspectives Nutrients 2026 18 594 10.3390/nu18040594 41754115 PMC12943770
46. Gems D. Doonan R. Antioxidant defense and aging in C. elegans: Is the oxidative damage theory of aging wrong? Cell Cycle 2009 8 1681 1687 10.4161/cc.8.11.8595 19411855
Figure 1

Box plots referring to the median (25th and 75th percentiles) of vitamin A serum levels and the number of diseases present at the baseline in the studied population. Statistical analysis was performed by chi-square for trend.

Figure image at the original source: open the original paper. This file is not included in this text import.
Table 1

Main demographic, social and clinical characteristics of the studied subjects. Categorical variables are reported as frequencies (%), and continuous variables are reported as medians (interquartile ranges).

N = 500
Age (years)60.7 (48.4 to 71.9)
Male gender202 (40.4)
BMI (Kg/m2)25.0 (22.4 to 28.0)
Living region
North Italy362 (72.4)
Central Italy88 (17.6)
South Italy50 (10.0)
Job type
Stable employment164 (32.9)
Occasional work60 (12.0)
Not working101 (20.2)
Student13 (2.6)
Retired161 (32.3)
Education level
Primary school109 (21.8)
Middle school186 (37.2)
High school151 (30.2)
College54 (10.8)
Presence of cancer38 (7.6)
CAD27 (5.4)
History of stroke11 (2.2)
Presence of diabetes55 (11)
Respiratory diseases28 (5.6)
Arterial hypertension173 (34.6)
Osteoporosis86 (17.2)
Active smoking86 (17.2)

BMI: body mass index; CAD: coronary artery disease.

Table 2

Baseline main biochemical parameters and serum vitamin levels of the studied subjects. The variables are reported as medians (interquartile ranges).

N = 500
Hemoglobin (g/dL)13.8 (13.0 to 14.7)
MCV (fL)91.2 (88.5 to 94.4)
Platelets (n * 1000/mL)222 (190 to 258)
WBCs (n * 1000/mL)6.01 (4.99 to 7.26)
Creatinine (mg/dL)0.88 (0.77 to 1.00)
Uric acid (mg/dL)4.6 (3.8 to 5.6)
Ca (mMol/L)2.36 (2.30 to 2.43)
P (mMol/L)1.07 (0.95 to 1.19)
iPTH (pg/mL)57.6 (43.5 to 78.5)
25-OH-vitamin D (ng/mL)20.4 (14.0 to 26.1)
Vitamin A (μg/L)654 (550 to 771)
Vitamin E (mg/L)11.3 (8.2 to 14.1)

MCV: mean corpuscular volume; WBCs: white blood cells; Ca: serum calcium, P: serum phosphorus; iPTH: serum parathormone.

Table 3

Vitamin D, vitamin A, and vitamin E serum concentrations in relation to demographic, clinical, and biochemical parameters in the studied population. Spearman’s rank correlation coefficient rho (r) was calculated and is presented.

25-OH-Vitamin D25-OH-Vitamin D
(Corrected for Season)
Vitamin AVitamin E
Corr. Coeff.
ρ
p Corr. Coeff.
ρ
p Corr. Coeff.
ρ
p Corr. Coeff.
ρ
p
Age (years)−0.2010<0.001−0.1533<0.0010.07880.07850.2785<0.001
Gender (f = 0/m = 1)−0.00300.94650.00650.88430.2023<0.001−0.00150.9726
Living region
North Italy (0)
Central Italy (1)
South Italy (2)
0.1950<0.0010.05280.2383−0.08880.0472−0.4578<0.001
Education (0 = primary, 1 = middle, 2 = high, or 3 = university)0.07760.08290.07060.1148−0.01850.6806−0.12020.0071
Job (0 = no, 1 = occasional, 2 = stable, 3 = retired, or 4= student)−0.04300.33730.00070.9878−0.00730.87130.07330.1017
BMI (Kg/m2)−0.03980.3743−0.03300.46210.2157<0.0010.03510.4336
Smoking (no = 0/y = 1)0.02150.63090.01880.67440.12430.0054−0.02770.5360
Creatinine (mg/dL)−0.05060.2589−0.01380.75840.3098<0.0010.06620.1395
Uric acid (mg/dL)−0.03340.4556−0.01770.69370.3186<0.0010.05600.2115
Ca (mMol/L)0.07810.08120.07550.09160.2133<0.0010.06010.1796
P (mMol/L)0.05950.18410.01640.7143−0.08460.05870.02810.5301
iPTH (pg(mL)−0.3407<0.001−0.3007<0.001−0.10300.02120.13660.0022
iPTH (pg(mL) season-corrected)−0.3303<0.001−0.3072<0.001−0.10600.01780.11530.0099
WBCs (n * 1000/mL)−0.00460.9174−0.01220.78510.2702<0.001−0.03790.3977
Hemoglobin (g/dL)0.02090.64120.06140.17050.2386<0.0010.1480<0.001
Platelets (n * 1000/mL)0.0840.06580.12830.00410.1489<0.0010.1793<0.001

BMI: body mass index; WBCs: white blood cells; Ca: serum calcium, P: serum phosphorus; iPTH: serum parathormone.

Table 4

25-OH-vitamin D, vitamin A and vitamin E serum concentrations in relation to the presence of diseases evaluated in the studied population. Medians (interquartile ranges) and rank-sum test (Mann: Whitney) comparisons are presented.

25-OH-Vitamin D
(ng/mL)
Vitamin A
(mg/L)
Vitamin E
(mg/L)
PresentAbsent p PresentAbsent p PresentAbsent p
Osteoporosis
(N = 107)
18.1
(11.6 to 25.6)
21.1
(14.9 to 26.2)
0.0146670
(570 to 800)
645
(544 to 766)
0.060118.1
(11.6 to 25.6)
11.0
(7.8 to 13.8)
0.0082
Arterial hypertension
(N = 173)
19.2
(12.8 to 25.1)
21.1
(15.0 to 26.4)
0.0473670
(570 to 808)
647
(532 to 758)
0.004711.8
(9.0 to 14.3)
10.8
(7.8 to 14.0)
0.0846
Diabetes
(N = 55)
22.3
(13.5 to 28.3)
20.2
(14.1 to 26.0)
0.2715693
(551 to 905)
650
(548 to 763)
0.036311.2
(7.6 to 13.7)
11.3
(8.4 to 14.2)
0.4409
Respiratory diseases
(N = 28)
18.8
(12.4 to 24.5)
20.5
(14.3 to 26.4)
0.1115621
(501 to 744)
656
(554 to 772)
0.318810.8
(9.2 to 12.3)
11.4
(8.1 to 14.3)
0.5902
CAD
(N = 27)
13.7
(8.7 to 23.7)
20.6
(14.6 to 26.3)
0.0017625
(538 to 733)
655
(551 to 772)
0.363511.0
(8.4 to 13.6)
11.3
(8.2 to 14.1)
0.6787
History of stroke
(N = 11)
20.0
(12.8 to 31.8)
20.5
(14.1 to 26.1)
0.9470745
(518 to 870)
625
(551 to 770)
0.28009.0
(7.6 to 12.3)
11.4
(8.2 to 14.2)
0.1102
Presence of cancer
(N = 38)
16.7
(12.4 to 24.3
20.5
(14.4 to 26.2)
0.1387727
(574 to 880)
650
(545 to 763)
0.010112.1
(9.6 to 14.1)
11.2
(8.1 to 14.1)
0.1743

CAD: coronary artery disease.

Table 5

Association between demographic, clinical, and biochemical parameters, and presenting at baseline one or less (N = 412) versus more than one (two to five) chronic disease (N = 88) in the studied population. Spearman’s rank correlation rho was calculated and presented in the univariate analysis. Stepwise logistic regression with a forward approach was used to discriminate variables independently associated with the presence of two or more diseases.

Presence of >1 Diseases at Baseline
Univariate AnalysisMultivariate Logistic
Regression Analysis
ρ p OR95% CI p
Age (years)0.32130.00001.0681.047 to 1.089<0.001
Gender (f = 0/m = 1)0.24030.00002.2591.330 to 3.8370.003
Living region
North Italy (0)
Central Italy (1)
South Italy (2)
−0.14460.0012Not reportedNot reportedNot reported
Education (0 = primary, 1 = middle, 2 = high, or 3 = university)−0.23780.0000Not reportedNot reportedNot reported
Job (0 = no, 1 = occasional, 2 = stable, 3 = retired, or 4= student)0.13230.0030Not reportedNot reportedNot reported
BMI (Kg/m2)0.21630.00001.0691.010 to 1.1310.021
Smoking (no = 0/y = 1)−0.02970.5072
Creatinine (mg/dL)0.19670.0000Not reportedNot reportedNot reported
Uric acid (mg/dL)0.24010.0000Not reportedNot reportedNot reported
Ca (mMol/L)0.02320.6052
P (mMol/L)−0.11130.0127
iPTH (pg/mL)0.06540.1441
WBCs (n * 1000/mL)0.01260.7785
Hemoglobin (g/dL)0.00750.8666
Platelets (n * 1000/mL)−0.06330.1578
25-OH-vitamin D (ng/mL)−0.07950.0758Not reportedNot reportedNot reported
Vitamin A (mg/L)0.14030.00171.0031.001 to 1.131<0.001
Vitamin E (mg/L)0.02400.5919

BMI: body mass index; WBCs: white blood cells; Ca: serum calcium, P: serum phosphorus; iPTH: serum parathormone.

Table 6

Association between demographic, clinical, and biochemical parameters (N = 500), with the presence of cancer at baseline in the studied population. Spearman’s rank correlation rho was calculated and presented in univariate analysis. Stepwise regression with a forward approach was used to discriminate variables independently associated with the presence of cancer.

Presence of Cancer (N = 38)
Univariate AnalysisMultivariate Logistic
Regression Analysis
ρ p OR95% CI p
Age (years)0.16910.00011.0441.019 to 1.069<0.001
Gender (f = 0/m = 1)0.10230.0222Not reportedNot reportedNot reported
Living region
North Italy (0)
Central Italy (1)
South Italy (2)
−0.10570.0181Not reportedNot reportedNot reported
Education (0 = primary, 1 = middle, 2 = high, or 3 = university)−0.04590.3054
Job (0 = no, 1 = occasional, 2 = stable, 3 = retired, or 4= student)0.05750.1991
BMI (Kg/m2)0.06490.1472
Smoking (no = 0/y = 1)−0.09070.0426Not reportedNot reportedNot reported
Creatinine (mg/dL)0.08840.0482Not reportedNot reportedNot reported
Uric acid (mg/dL)0.10170.0230Not reportedNot reportedNot reported
Ca (mMol/L)−0.02700.5462
P (mMol/L)−0.03340.4556
iPTH (pg/mL)−0.00550.9030
WBCs (n * 1000/mL)−0.02210.6217
Hemoglobin (g/dL)−0.01850.6796
Platelets (n * 1000/mL)−0.00550.9021
25-OH-vitamin D (ng/mL)−0.06630.1389
Vitamin A (mg/L)0.11510.01001.0021.000 to 1.0040.014
Vitamin E (mg/L)0.06080.1746

BMI: body mass index; WBCs: white blood cells; Ca: serum calcium, P: serum phosphorus; iPTH: serum parathormone.

Publication and source details

Original title: Serum Vitamin D, A, and E Concentrations and Their Associations with Chronic Diseases in Adult Patients Referred to Italian General Practitioners’ Offices

Paolo Baron; Diego Bigotto; Elena Brignolo; Gabriella Maria Camusso; Alberto Cannavino; Norberto Carli; Francesco Castronuovo; Carmine Colleluori; Provvidenza Fazio; Roberto Ferroni Nichelino; Giorgio Fiorello Chieri; Francesco Fontana; Lino Gambardelli; Patrizia Mascarello; Gabriella Musica; Claudio Nardo; Immacolata Piccirillo; Herbert Rainer; Alberto Rolfo; Stefano Vignando; Sara Cmet; Annarosa Cussigh; Edmondo Falleti; Pierluigi Toniutto

Nutrients · 2026

* Correspondence: pierluigi.toniutto@uniud.it; Tel.: +39-0432-552636© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.This research received no external funding.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T16:35:06.670349+00:00

DOI: 10.3390/nu18060943 · PMC13029338